Raymond Yee

Raymond Yee

Auto-generated profile, based on publicly available information

Raymond Yee

London Health Sciences Center, London, Ontario, Canada

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2003 in The American Journal of Medicine
Verified
Journal Article
Closed access
SSSoori Sivakumaran
Soori Sivakumaran
AKAndrew D Krahn
Andrew D Krahn
GKGeorge J Klein
George J Klein
JFJane Finan
Jane Finan
RYRaymond Yee
Raymond Yee
ASAllan C Skanes
Allan C Skanes

1 January 2016 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
YMYoko Mikami
Yoko Mikami
ACAidan Cornhill
Aidan Cornhill
BHBobak Heydari
Bobak Heydari
SJSebastien X. Joncas
Sebastien X. Joncas
FAFahad Almehmadi
Fahad Almehmadi
JWJames A. White
James A. White
Expert subjective reporting of mid-wall septal fibrosis on late gadolinium enhancement (LGE) images has been shown to predict major cardiovascular outcomes in patients with non-ischemic dilated cardiomyopathy (NIDCM). This study aims to establish objective criteria for non-experts to report clinically relevant septal fibrosis and compare its performance by such readers versus experts for the prediction of cardiovascular events. LGE cardiovascular magnetic resonance (CMR) was performed in 118 consecutive patients with NIDCM (mean age 57 ± 14, 42 % female) and the presence of septal fibrosis scored by expert readers. CMR-naive readers performed signal threshold-based LGE quantification by referencing mean values of remote tissue and applying these to a pre-defined anatomic region to measure septal fibrosis. All patients were followed for the primary composite outcome of cardiac mortality or appropriate implantable cardioverter-defibrillator (ICD) therapy. The mean LVEF was 32 ± 12 %. At a median follow-up of 1.9 years, 20 patients (17 %) experienced a primary composite outcome. Expert visual scoring identified 55 patients with septal fibrosis. Non-expert septal fibrosis quantification was highly reproducible and identified mean septal fibrosis burden for three measured thresholds as follows; 5SD: 2.9 ± 3.6 %, 3SD: 6.9 ± 6.3 %, and 2SD: 11.1 ± 7.5 % of the left ventricular (LV) mass, respectively. By ROC analysis, optimal thresholds for prediction of the primary outcome were; 5SD: 2.74 % (HR 8.7, p < 0.001), 3SD: 6.63 % (HR 5.7, p = 0.001) and 2SD: 10.15 % (HR 6.1, p = 0.001). By comparison, expert visual scoring provided a HR of 5.3 (p = 0.001). In adjusted analysis, objective quantification by a novice reader (>5SD threshold) was the strongest independent predictor of the primary outcome (HR 8.7) and provided improved risk reclassification beyond LVEF alone (NRI 0.54, 95 % CI 0.16–0.92, p = 0.005). Novice readers were able to achieve superior risk prediction for future cardiovascular events versus experts using objective criteria for septal fibrosis in patients with NIDCM. Patients with a septal fibrosis burden >2.74 % of the LV mass (>5SD threshold) were at a 9-fold higher risk of cardiac death or appropriate ICD therapy versus those not meeting this criteria. As such, this study validates reproducible criteria applicable to all levels of expertise to identify NIDCM patients at high risk of future cardiovascular events.

1 June 2013 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
RYRaymond Yee
Raymond Yee
AVAtul Verma
Atul Verma
MBMarianne Beardsall
Marianne Beardsall
JFJennifer Fraser
Jennifer Fraser
FPFrancois Philippon
Francois Philippon
DEDerek V. Exner
Derek V. Exner

6 December 2007 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
DRDamian P. Redfearn
Damian P. Redfearn
LGLorne J. Gula
Lorne J. Gula
AKAndrew D. Krahn
Andrew D. Krahn
ASAllan C. Skanes
Allan C. Skanes
GKGeorge J. Klein
George J. Klein
RYRaymond Yee
Raymond Yee

1 September 2017 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
RYRaymond Yee
Raymond Yee
JFJohn D. Fisher
John D. Fisher
UBUlrika Birgersdotter-Green
Ulrika Birgersdotter-Green
TSTimothy W. Smith
Timothy W. Smith
DKDavid N. Kenigsberg
David N. Kenigsberg
PDPaul DeGroot
Paul DeGroot
Background: Antitachycardia pacing (ATP) in implantable cardioverter-defibrillators (ICD) decreases patient shock burden but has recognized limitations. A new automated ATP (AATP) based on electrophysiological first principles was designed. The study objective was to assess the feasibility and safety of AATP in ambulatory ICD patients. Methods and Results: Enrolled patients had dual chamber or cardiac resynchronization therapy ICDs, history of ≥1 ICD-treated ventricular tachycardias (VT)/ventricular fibrillation episode, or a recorded, sustained monomorphic VT. Detection was set to ventricular fibrillation number of intervals to detect=24/32, VT number of intervals to detect≥16, and a fast VT zone of 240 to 320 ms. AATP prescribed the components and delivery of successive ATP sequences in real time, using the same settings for all patients. ICD datalogs were uploaded every ≈3 months, at unscheduled visits, exit, and death. Episodes and adverse events were adjudicated by separate committees. Results were adjusted (generalized estimating equations) for multiple episodes. AATP was downloaded into the ICDs of 144 patients (121 men), aged 67.4±11.9 years, left ventricular ejection fraction 33.1±13.6% (n=137), and treated 1626 episodes in 49 patients during 14.5±5.1 months of follow-up. Datalogs permitted adjudication of 702 episodes, including 669 sustained monomorphic VT, 20 polymorphic VT, 10 supraventricular tachycardia, and 3 malsensing episodes. AATP terminated 39 of 69 (59% adjusted) sustained monomorphic VT in the fast VT zone, 509 of 590 (85% adjusted) in the VT zone, and 6 of 10 in the ventricular fibrillation zone. No supraventricular tachycardias converted to VT or ventricular fibrillation. No anomalous AATP behavior was observed. Conclusions: The new AATP algorithm safely generated ATP sequences and controlled therapy progression in all zones without need for individualized programing.

1 July 2014 in Heart Rhythm
Verified
Journal Article
Closed access
RYRaymond Yee
Raymond Yee
FGFredrik Gadler
Fredrik Gadler
AHAzlan Hussin
Azlan Hussin
RORazali Bin Omar
Razali Bin Omar
YKYaariv Khaykin
Yaariv Khaykin
KMKyle R. Marquard
Kyle R. Marquard